Skip to main content
Year archive

Moberg Pharma — 2026 filings

All 16 regulatory filings released by Moberg Pharma (MOB) in 2026, sourced directly from the official regulator.

16 Filings
2026 Period
2026 filings (16)
Filing Released Lang
Moberg Pharma and Karo Healthcare expand collaboration for MOB-015/Terclara to China
Regulatory Filings
2026-06-08 English
Moberg Pharma och Karo Healthcare expanderar samarbete för MOB-015/Terclara till Kina
Regulatory Filings
2026-06-08 Swedish
Major Shareholding Notification 2026
Major Shareholding Notification
2026-06-03 English
Kommuniké från Moberg Pharmas årsstämma den 21 maj 2026
Declaration of Voting Results & Voting Rights Announcements
2026-05-21 Swedish
Bulletin from Moberg Pharma’s AGM on May 21[st], 2026
Declaration of Voting Results & Voting Rights Announcements
2026-05-21 English
Interim / Quarterly Report 2026
Interim / Quarterly Report Q1 2026
2026-05-12 Swedish
Interim / Quarterly Report 2026
Interim / Quarterly Report Q1 2026
2026-05-12 English
Moberg Pharma och Karo Healthcare expanderar samarbete för MOB-015/Terclara till Australien, Nya Zeeland, Sydkorea och Taiwan
Regulatory Filings
2026-04-24 Swedish
Moberg Pharma and Karo Healthcare expand collaboration for MOB-015/Terclara to Australia, New Zealand, South Korea and Taiwan
Regulatory Filings
2026-04-24 English
Notice of Annual General Meeting in Moberg Pharma AB (publ)
AGM Information
2026-04-17 English
Kallelse till årsstämma i Moberg Pharma AB (publ)
Proxy Solicitation & Information Statement
2026-04-17 Swedish
Annual Report 2025
Annual Report FY 2025
2026-04-17 Swedish
Additional terbinafine supplier approved
Regulatory Filings
2026-03-13 English
Ytterligare en terbinafin-leverantör godkänd
Regulatory Filings
2026-03-13 Swedish
Earnings Release 2025
Earnings Release Q4 2025
2026-02-17 Swedish
Audit Report / Information 2025
Audit Report / Information FY 2025
2026-02-17 English